MedTech Concept LLC is a med tech company based in Delaware USA focused on diabetes healthcare.
Our mission is to improve the health of diabetics by developing innovative medical products and exploiting the latest advances in computer software technology including artificial intelligence and collaboration technology. At launch we will be the only miniature delivery device on the market with multiple patents protecting our lead.
All governments worldwide are looking to reduce diabetes medical costs. We will help them achieve this goal through lower charges and improvements in diabetic healthcare. We offer a superior product at significantly lower cost, which will drive adoption among those who pay for diabetes healthcare (both individuals and governments).
Market research has confirmed great interest especially among travelers, the young, the active and those struggling to manage their diabetes.
Our diabetes management system combines the latest in digital health software with a market tested miniature therapeutic delivery device to provide real improvements in the control of diabetes.
The MiniPen2™ mini pen addresses the real world needs of diabetics replacing large, cumbersome and mostly high cost Insulin devices.
Our concept miniaturized therapeutic delivery solution MiniPen2™ will transform the lives of hundreds of thousands of Diabetics. Due to its low price it will be available to a far wider audience than the current range of large and expensive auto-injectors.
The MiniPen2™ offers diabetics an alternative to insulin pens, pumps and syringes by providing a small, low cost and convenient solution that provides a noticeable improvement in quality of life.
The MiniPen2™ takes on the safety of a syringe to the next level.
Our new safety feature lock system prevent the use for more than one time only. After the syringe have been filled with insulin or fluid, the plunger will automatically lock into the barrel and prevent usage again. This will stop the spread of viruses and infections!
Sign up to hear from us.
Most existing insulin delivery systems are large, cumbersome, indiscreet and expensive. Early adopters of the Minipen have noticed a huge improvement in freedom and reduced impact upon their daily lives using the MiniPen™.
Our business model is to create a grass roots loyal customer base that generates repeat business while targeting governments and health ministries looking to reduce the cost of diabetes care on a national scale.
Our mission is to make it possible to live close to a normal life with diabetes without any complications.
We strive to give our patients the best treatment to achieve a good HbA1c average level.
Medical software synced with self tests and clinic lab tests. Overview by a central team of doctors. The MiniPen is a key component of our comprehensive InsuManage.
Enhanced miniaturized insulin delivery systems
Future Research (Subject to Funding)
All orders are custom made by the requirements from the client. The miniPen 1 is available in different sizes from 10 to 100 unit. Dose gradings on the the barrel u40, u100, u200. Needle length 4-12mm. Thickness 29 - 32 gauge. Packing in box with 100pcs. Minimum order 100.000 boxes.
Areas of use: Insulin, Botox
The miniPen 2 is unique in the world with our patented safety feature "prevention of reuse". Available in different sizes from 10 to 100 unit. Dose gradings on the the barrel u40, u100, u200. Needle length 4-24mm. Thickness29 - 32 gauge. Packing in box with 100pcs. Minimum order 100.000 boxes. Areas of use: Insulin
The safety syringe is encased in the holder which seals tightly against the lid and therefore extra protected against dirt and bacteria. The size can vary from 0.1 ml to 3ml, the needle is available in different lengths and thicknesses according to the customer's requirements. Minimum order 10 million pcs.
PhD (Tech). Patent Lawyer
Has worked for many years as a patent agent, and is former patent director and senior consultant at Albihns AB. He is also a partner in Zacco Group, one of Europes leading consultant companies in intellectual property law. He is presently active in Brolin IP Services AB.
Type one diabetic.
Founder and inventor of the MiniPen systems.
MedTech Concept LLC
919N, Market Street,
Please send us a message or call us for an appointment.
+46709988357 Whatsapp, Telegram
Delaware, United States